ORGANIZATION AND OPERATIONS - Change In Control (Details Narrative)	6 Months Ended
	Jun. 30, 2024
Restructuring Cost and Reserve [Line Items]
Business Acquisition, Planned Restructuring Activities, Description	As a result of the purchase by Dimitar Slavchev Savov of a total of 11,489,000 (87%) shares of common stock of the Corporation from Mr. Ray and other shareholders, a change in control of the Company occurred as of April 1, 2022
Nika Europe Ltd
Restructuring Cost and Reserve [Line Items]
Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage	40.00%
Spinoff [Member]
Restructuring Cost and Reserve [Line Items]
Business Acquisition, Planned Restructuring Activities, Description	On January 6, 2022, Venture Growth Equities, Inc, was spun out and signed over to Mr. Ray, thus no longer making it a subsidiary of the Company.
Employee Relocation [Member] \| Director [Member]
Restructuring Cost and Reserve [Line Items]
Business Acquisition, Planned Restructuring Activities, Description	Effective as of March 31, 2022, the board of directors appointed Dimitar Slavchev Savov, and Clifford Redekop to serve as the Registrant’s Directors.
Employee Severance [Member] \| Phil Ray [Member]
Restructuring Cost and Reserve [Line Items]
Business Acquisition, Planned Restructuring Activities, Description	On March 31, 2022, Mr. Phil E. Ray resigned his position as a Director, President and Chief Executive Officer of the Company.
Employee Severance [Member] \| A Terry [Member]
Restructuring Cost and Reserve [Line Items]
Business Acquisition, Planned Restructuring Activities, Description	On March 31, 2022, Mrs. A. Terry. Ray resigned her position as a Director and Secretary of the Company.

NIKA PHARMACEUTICALS, INC 10-Q